New medical cooperation boosts cardiovascular disease control in China

The world-leading New England Journal of Medicine reached a collaboration agreement with Chinese Cardiovascular Association on Thursday to boost cardiovascular disease research and talent training in China.

Previously, NEJM Group has kicked off cooperation with Shanghai-based Jiahui Medical Research and Education Group to introduce a weekly Chinese e-journal, to introduce the latest studies and scientific research published on NEJM to speed up cardiovascular disease prevention and control in China. 

Cardiovascular disease is the top killer in China, being responsible for over 40 percent of total deaths in the nation annually, a figure much higher than tumors and other diseases.

There are about 290 million people with cardiovascular diseases in China, creating a serious public health problem and a strong burden on both families and society, health authorities said.